查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529863

荷尔蒙避孕药市场规模、份额、趋势分析报告：依方法、按荷尔蒙、按地区、细分市场预测，2024-2030

Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, IUD), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

荷尔蒙避孕药市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球荷尔蒙避孕药市场规模将达到212.1亿美元，2024年至2030年复合年增长率为4.01%。

市场成长预计将由创新产品的推出和新兴地区生殖健康意识的提高所推动。在新兴经济体，由于政府措施和计画的增加，越来越多的女性开始使用避孕器，预计将加速市场成长。例如，根据联合国《2022年世界生育和计划生育报告》，到2021年，19亿育龄妇女将使用某种形式的避孕措施来避免怀孕，其中77%的妇女植入、贴片或子宫内节育器。

根据联合国人口基金会 (UNFPO) 的《2022 年世界人口状况》，全球整体每年 1.21 亿例怀孕中，约有 50% 是意外怀孕。根据《看到未见之事：在被忽视的意外怀孕危机中采取行动的案例》，超过60% 的意外怀孕以堕胎告终；因此，为了避免不安全堕胎，各国正在传播避孕措施的意识，这是预期的结果。

由于市场竞争激烈，企业在研发方面投入大量资金。我们也采取多种策略，包括併购和扩大产品平臺。例如，2022年2月，欧加农集团从拜耳公司收购了口服荷尔蒙每日避孕药Mercilon和Marvelon在中华人民共和国（包括澳门和香港）的权利。此外，我们已同意在越南取得这些产品的权利。此次收购旨在获得全球（不包括韩国）这些品牌的所有权。

荷尔蒙避孕市场报告亮点

  • 从某种程度上来说，药物在 2023 年占据了市场主导地位。这是由于高效且简单的剂量、现成的产品、由于与长效可逆装置相比较早推出而提高的市场认知度、正确使用的约99% 的功效以及众多的原因。存在有助于成长领域。
  • 以荷尔蒙来看，由于副作用较少且出现痤疮及相关症状的机会较小，复合荷尔蒙避孕药将在 2023 年占据市场主导地位。
  • 2023年北美地区占最大市场占有率。这是由于大公司的存在、意外怀孕率高、人均收入高、政府的支持措施。
  • 2023 年 6 月，製药公司 Gedeon Richter UK Limited 以 3,517 万美元（3,250 万欧元）从 Consilient Health Ltd. 收购了品牌非专利药避孕药的全部行销和分销权。此次收购旨在以实惠的价格在英国各地提供该产品。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 波特五力分析
    • PESTLE分析

第 4 章业务分析：按方法

  • 2023 年和 2030 年按方法市场占有率
  • 按方法细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析（依方法）
  • 丸
    • 2018-2030 年药品市场估计与预测
  • IUD
    • 2018-2030 年子宫内避孕器市场估计与预测
  • 注射
    • 2018-2030 年註射药品市场估计与预测
  • 避孕环
    • 2018-2030 年避孕环市场估计与预测
  • 植入
    • 2018-2030 年植入市场估计与预测
  • 修补
    • 2018-2030 年补丁市场估计与预测

第五章业务分析：依荷尔蒙分类

  • 2023 年和 2030 年市场占有率
  • 荷尔蒙细分仪表板
  • 2018-2030年荷尔蒙市场规模及预测与趋势分析
  • 合併荷尔蒙避孕
    • 2018-2030 年联合荷尔蒙避孕药市场估计与预测
  • 仅孕激素
    • 2018-2030 年纯黄体素市场估计与预测

第 6 章 按方法和类型分類的区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 2018-2030 年北美荷尔蒙避孕药市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030 年欧洲荷尔蒙避孕药市场估计与预测
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太地区荷尔蒙避孕药市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲激素避孕药市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲荷尔蒙避孕市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与企业概况
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/名单
    • AbbVie Inc.
    • Bayer AG
    • Organon group of companies.
    • Pfizer Inc.
    • Afaxys, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Agile Therapeutics
    • Johnson &Johnson Services, Inc.
    • Lupin Pharmaceuticals, Inc.
    • Pregna International Limited.
Product Code: GVR-2-68038-348-5

Hormonal Contraceptive Market Growth & Trends:

The global hormonal contraceptive market size is anticipated to reach USD 21.21 billion by 2030, growing at a CAGR of 4.01% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is expected to be driven by the introduction of innovative products and increasing awareness about reproductive health in emerging regions. More women in developing economies are using contraceptives due to the rise in government initiatives and programs, which is anticipated to accelerate market growth. For instance, according to the UN World Fertility and Family Planning 2022, in 2021, 1.9 billion women of reproductive age received some form of contraception to avoid pregnancy with 77% of women among them using modern contraceptive methods including implants, patches, IUDs, and others.

According to the State of World Population 2022, by UNFPO, globally, approximately 50% of all 121 million pregnancies each year are unwanted. As per the Seeing the Unseen report: The case for action in the neglected crisis of unintended pregnancy, more than 60% of unwanted pregnancies result in abortion and the projected 45% among them are unsafe. Hence, to avoid unsafe abortions, countries are spreading awareness about contraceptives, which is expected to propel industry growth.

Due to the highly competitive nature of the market, companies are making significant investments in research and development. They are also adopting various strategies such as mergers and acquisitions and expanding their product pipelines. For instance, in February 2022, Organon Group of Companies acquired rights of Mercilon and Marvelon, combined oral hormonal daily contraceptive pills from Bayer AG in the People's Republic of China, including Macau and Hong Kong. In addition, it has agreed to acquire rights in Vietnam to these products. This acquisition aims to provide global ownership rights of these brands, except in South Korea.

Hormonal Contraceptive Market Report Highlights:

  • Based on method, the pill segment dominated the market in 2023 owing to the efficient and straightforward administration, readily accessible products, enhanced market awareness due to early introduction compared to long-acting reversible devices, and an approximate 99% effectiveness with proper usage, and the presence of many players contribute to the segment growth.
  • Based on hormone, the combination hormonal contraceptive segment dominated the market in 2023 owing to the fewer side effects and lower chances of developing acne and related symptoms.
  • North America region held the largest market share in 2023. This can be attributed to the existence of major players, a high proportion of unwanted pregnancies, high per capita income, and supportive government initiatives.
  • In June 2023, Gedeon Richter UK Limited, a pharmaceutical company, acquired full distribution and marketing rights of a contraceptive range of branded generics from Consilient Health Ltd. for USD 35.17 million (Euro 32.5 million). This acquisition aims to provide this product at affordable prices across the UK.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Method
    • 1.2.2. Hormone
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
    • 1.8.2. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in government and NGO initiatives to promote contraceptive methods
      • 3.2.1.2. High unmet needs
      • 3.2.1.3. Increasing R&D investments
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Rapidly aging population and rising prevalence of infertility
      • 3.2.2.2. Adverse effects associated with the use of contraceptive drugs and devices
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Method Business Analysis

  • 4.1. Method Market Share, 2023 & 2030
  • 4.2. Method Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 4.4. Pill
    • 4.4.1. Pill market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. IUD
    • 4.5.1. IUD market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Injectable
    • 4.6.1. Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Vaginal Ring
    • 4.7.1. Vaginal ring market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Implant
    • 4.8.1. Implant market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.9. Patch
    • 4.9.1. Patch market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hormone Business Analysis

  • 5.1. Hormone Market Share, 2023 & 2030
  • 5.2. Hormone Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, by Hormone, 2018 to 2030 (USD Million)
  • 5.4. Combination Hormonal Contraceptives
    • 5.4.1. Combination hormonal contraceptives market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Progestin Only
    • 5.5.1. Progestin only market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Estimates & Trend Analysis by Method & Type

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 6.4. North America
    • 6.4.1. North America hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. U.S. hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Canada hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Mexico hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. UK
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. UK hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. France hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Italy hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Spain hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Denmark hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Sweden hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive scenario
      • 6.5.9.4. Norway hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Japan hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. China hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. India hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Australia hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Thailand hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Brazil hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. Argentina hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. South Africa hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Saudi Arabia hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. UAE hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive scenario
      • 6.8.5.4. Kuwait hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. AbbVie Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Bayer AG
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Organon group of companies.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Pfizer Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Afaxys, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Teva Pharmaceutical Industries Ltd.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Agile Therapeutics
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Johnson & Johnson Services, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Lupin Pharmaceuticals, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Pregna International Limited.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 4 Global hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 5 Global hormonal contraceptive market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 8 North America hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 9 U.S hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 10 U.S hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 11 Canada hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 12 Canada hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 13 Mexico hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 14 Mexico hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 15 Europe hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 17 Europe hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 18 UK hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 19 UK hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 20 Germany hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 21 Germany hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 22 France hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 23 France hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 24 Italy hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 25 Italy hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 26 Spain hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 27 Spain hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 28 Norway hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 29 Norway hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 30 Sweden hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 31 Sweden hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 32 Denmark hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 33 Denmark hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 37 Japan hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 38 Japan hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 39 China hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 40 China hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 41 India hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 42 India hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 43 Australia hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 44 Australia hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 45 South Korea hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 46 South Korea hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 47 Thailand hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 48 Thailand hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 49 Latin America hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 51 Latin America hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 52 Brazil hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 53 Brazil hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 54 Argentina hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 55 Argentina hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 59 South Africa hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 60 South Africa hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 63 UAE hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 64 UAE hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 65 Kuwait hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 66 Kuwait hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's Five Forces analysis
  • Fig. 16 Hormonal contraceptive market: Method outlook and key takeaways
  • Fig. 17 Hormonal contraceptive market: Method movement analysis
  • Fig. 18 Pill market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 IUD market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 Injectable market revenue, 2018 - 2030 (USD Million)
  • Fig. 21 Vaginal ring market revenue, 2018 - 2030 (USD Million)
  • Fig. 22 Implant market revenue, 2018 - 2030 (USD Million)
  • Fig. 23 Patch market revenue, 2018 - 2030 (USD Million)
  • Fig. 24 Hormonal contraceptive market: Hormone outlook and key takeaways
  • Fig. 25 Hormonal contraceptive market: Hormone movement analysis
  • Fig. 26 Combined hormone contraceptive market revenue, 2018 - 2030 (USD Million)
  • Fig. 27 Progestin only market revenue, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2023 & 2030
  • Fig. 30 Hormonal contraceptive market: Region movement analysis
  • Fig. 31 North America hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 32 US hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Europe hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Sweden hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Asia Pacific hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Latin America hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Middle East and Africa hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Company categorization
  • Fig. 83 Strategy mapping
  • Fig. 84 Company market position analysis